Genfit (France) Performance
| GNFT Stock | EUR 3.37 0.04 1.20% |
The company retains a Market Volatility (i.e., Beta) of 0.27, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Genfit's returns are expected to increase less than the market. However, during the bear market, the loss of holding Genfit is expected to be smaller as well. At this point, Genfit has a negative expected return of -0.0469%. Please make sure to check out Genfit's treynor ratio, potential upside, and the relationship between the total risk alpha and maximum drawdown , to decide if Genfit performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Genfit has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Genfit is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 171 M | |
| Total Cashflows From Investing Activities | -3.4 M |
Genfit |
Genfit Relative Risk vs. Return Landscape
If you would invest 350.00 in Genfit on December 19, 2024 and sell it today you would lose (13.00) from holding Genfit or give up 3.71% of portfolio value over 90 days. Genfit is generating negative expected returns and assumes 1.7544% volatility on return distribution over the 90 days horizon. Simply put, 15% of stocks are less volatile than Genfit, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Genfit Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Genfit's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Genfit, and traders can use it to determine the average amount a Genfit's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0267
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | GNFT |
Estimated Market Risk
| 1.75 actual daily | 15 85% of assets are more volatile |
Expected Return
| -0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Genfit is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Genfit by adding Genfit to a well-diversified portfolio.
Genfit Fundamentals Growth
Genfit Stock prices reflect investors' perceptions of the future prospects and financial health of Genfit, and Genfit fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Genfit Stock performance.
| Return On Equity | 0.67 | |||
| Return On Asset | 0.15 | |||
| Profit Margin | 0.51 % | |||
| Operating Margin | 0.48 % | |||
| Current Valuation | 30.62 M | |||
| Shares Outstanding | 49.82 M | |||
| Price To Earning | (18.01) X | |||
| Price To Book | 1.51 X | |||
| Price To Sales | 1.75 X | |||
| Revenue | 80.07 M | |||
| EBITDA | 79.34 M | |||
| Cash And Equivalents | 69.05 M | |||
| Cash Per Share | 6.65 X | |||
| Total Debt | 72.05 M | |||
| Debt To Equity | 809.90 % | |||
| Book Value Per Share | 2.20 X | |||
| Cash Flow From Operations | 99.92 M | |||
| Earnings Per Share | 0.84 X | |||
| Total Asset | 281.72 M | |||
| Retained Earnings | (81 M) | |||
| Current Asset | 105 M | |||
| Current Liabilities | 12 M | |||
About Genfit Performance
By analyzing Genfit's fundamental ratios, stakeholders can gain valuable insights into Genfit's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Genfit has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Genfit has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Genfit SA, a biopharmaceutical company, develops therapeutic and diagnostic solutions for metabolic, inflammatory, and autoimmune or fibrotic diseases affecting primarily the liver and gastro-enterology. Genfit SA was founded in 1999 and is headquartered in Loos, France. GENFIT operates under Biotechnology classification in France and is traded on Paris Stock Exchange. It employs 148 people.Things to note about Genfit performance evaluation
Checking the ongoing alerts about Genfit for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Genfit help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Genfit generated a negative expected return over the last 90 days | |
| Genfit has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| About 13.0% of the company shares are held by company insiders |
- Analyzing Genfit's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Genfit's stock is overvalued or undervalued compared to its peers.
- Examining Genfit's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Genfit's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Genfit's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Genfit's stock. These opinions can provide insight into Genfit's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Genfit Stock analysis
When running Genfit's price analysis, check to measure Genfit's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genfit is operating at the current time. Most of Genfit's value examination focuses on studying past and present price action to predict the probability of Genfit's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genfit's price. Additionally, you may evaluate how the addition of Genfit to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |